logo transparent gif
top_left_edge top_white_spacer top_right_edge
Home Latest Forum Topics MyCorner - Personal Stocks Porfolio Stock Lists Forex Investor Insights Investment News Investor Research & Links Dynamic Stock Charting FREE Registration About Us top spacer top spacer
 User Password Auto-Login
Enter Stock
 
righttip
branding

Return

Biolidics

8YY

0.016

+ 0.001

GroupCash
CashSingapore Dollar

 

TRADING INFO


Open
0.015
Buy
0.015
Sell
0.016
High
0.016
Low
0.015
Previous Close
0.015
Volume(K)
3160.0
Buy Volume(K)
1054.0
Sell Volume(K)
730.9

KEY STOCK INFOUpdated: 21 Mar 2023


PE Ratio (FY)
NA
Dividend Yield % (FY)
-
Price to Book Ratio
-
Market Cap ($million)
-
Enterprise Value ($million)
-
52 Weeks High
0.125875057
52 Weeks Low
0.014
RSI
39.2 ( No Info )
Williams %R
-50.0 ( No Info )

 

COMPANY INFORMATION Updated: 18 Mar 2023 Financial Info by


SIC
MEDICAL LABORATORIES
Address
37 JALAN PEMIMPIN #02-07 MAPEX SINGAPORE 577177
Phone
(65)
Fax
(65) 6482 0668
Profile
We are a Singapore-based medical technology company focusing on the development of cellenrichment systems which, when combined with other analytical tests, have a wide range of</BR>applications for cancer diagnosis, prognosis, treatment selection and treatment monitoring.
AUDITOR
ERNST & YOUNG LLP

 

FINANICALS INFORMATION All values in $millions


Financial Year
Dec 31, 2020
Dec 31, 2021
Dec 31, 2022
Currency
SGD
SGD
SGD
KEY RATIOS
FY 2020
FY 2021
FY 2022

Operating Margin(%)
-51.15
-252.074
-388.992
Return on Equity Capital(%)
-57.99
-112.863
-2911.18
Net Profit Margin(%)
-52.21
-258.6
-376.617
Current Ratio
5.65
2.528
0.985
Debt to Capital at Book
0.28
0.372
0.495
INCOME STATEMENT
FY 2020
FY 2021
FY 2022

EBITDA
-3.03
-4.67
-8.58
EBIT
-4.03
-5.92
-9.77
Net Profit
-4.65
-5.98
-9.37
Ordinary Dividend
0
0
0
BALANCE SHEET
FY 2020
FY 2021
FY 2022

Intangibles
4.4
4.12
0
Fixed Assets
0.77
0.8
0.06
Long Term Investments
0
0
0
Stock/Inventories
1.61
1.51
0.03
Cash
10.67
3.96
5.03
Current Liabilities
2.29
2.42
6.01
Long Term Debt
3.76
2.74
1.69
Provisions
0.01
0.01
0.01
Minorities
0
0
0
Total Shareholder Equity
8.27
2.33
-1.69
PER SHARE INFO
FY 2020
FY 2021
FY 2022

EBITDA per share
-0.01
-0.018
-0.017
EBIT per share
-0.02
-0.023
-0.02
Profit Per Share
-0.02
-0.023
-0.019
Book Value Per Share
0.01
-0.007
-0.003

 

 


Intraday Chart




ShareJunction Version: 27 Nov 2020 ver- All Rights Reserved. Copyright ShareJunction Pte. Ltd. Disclaimer: All prices from are delayed. ShareJunction does not provide you with any financial advice. We are not into the business of providing any investment advice. See our Terms and Conditions and Privacy Policy of using this website. Data is delayed for varying periods of time depending on the exchange, but for at least 15 minutes. Copyright SIX Financial Information Ltd. and its licensors. All Rights reserved. Further distribution and use by third parties prohibited. SIX Financial Information and its licensors make no warranty for information displayed and accept no liability for data and prices. SIX Financial Information reserves the right to adapt and/or alter this website at any time without prior notice.

Web design by FoundationFlux.